|
| 36470426 | Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling. | J Biol Chem | 2023 |
| 36470426 | Mapping the KRAS proteoform landscape in colorectal cancer identifies truncated KRAS4B that decreases MAPK signaling. | J Biol Chem | 2023 |
| 35720974 | PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions. | Cell Genom | 2022 |
| 35720974 | PrecisionFDA Truth Challenge V2: Calling variants from short and long reads in difficult-to-map regions. | Cell Genom | 2022 |
| 33417831 | Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. | Cancer Cell | 2021 |
| 33577785 | Proteogenomic and metabolomic characterization of human glioblastoma. | Cancer Cell | 2021 |
| 34036290 | A community effort to identify and correct mislabeled samples in proteogenomic studies. | Patterns (N Y) | 2021 |
| 33417831 | Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. | Cancer Cell | 2021 |
| 34858420 | Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens. | Front Immunol | 2021 |
| 34671754 | Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. | Cell Rep Methods | 2021 |
| 33577785 | Proteogenomic and metabolomic characterization of human glioblastoma. | Cancer Cell | 2021 |
| 34858420 | Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens. | Front Immunol | 2021 |
| 34671754 | Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling. | Cell Rep Methods | 2021 |
| 34036290 | A community effort to identify and correct mislabeled samples in proteogenomic studies. | Patterns (N Y) | 2021 |
| 32529193 | Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability. | Cell Rep Med | 2020 |
| 32058701 | Deep Proteomics Using Two Dimensional Data Independent Acquisition Mass Spectrometry. | Anal Chem | 2020 |
| 31923397 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2020 |
| 32529193 | Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability. | Cell Rep Med | 2020 |
| 32954372 | Correction: Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability. | Cell Rep Med | 2020 |
| 32058701 | Deep Proteomics Using Two Dimensional Data Independent Acquisition Mass Spectrometry. | Anal Chem | 2020 |
| 31923397 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2020 |
| 32954372 | Correction: Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability. | Cell Rep Med | 2020 |
| 31467290 | A dataset describing a suite of novel antibody reagents for the RAS signaling network. | Sci Data | 2019 |
| 31585088 | Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. | Cell | 2019 |
| 31730861 | Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. | Cell | 2019 |
| 31675502 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2019 |
| 31467290 | A dataset describing a suite of novel antibody reagents for the RAS signaling network. | Sci Data | 2019 |
| 31730861 | Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. | Cell | 2019 |
| 31675502 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. | Cell | 2019 |
| 31585088 | Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. | Cell | 2019 |
| 29610327 | Precise characterization of KRAS4b proteoforms in human colorectal cells and tumors reveals mutation/modification cross-talk. | Proc Natl Acad Sci U S A | 2018 |
| 30194412 | Right data for right patient-a precisionFDA NCI-CPTAC Multi-omics Mislabeling Challenge. | Nat Med | 2018 |
| 30087585 | Residual tissue repositories as a resource for population-based cancer proteomic studies. | Clin Proteomics | 2018 |
| 29443976 | How many human proteoforms are there? | Nat Chem Biol | 2018 |
| 29610327 | Precise characterization of KRAS4b proteoforms in human colorectal cells and tumors reveals mutation/modification cross-talk. | Proc Natl Acad Sci U S A | 2018 |
| 30087585 | Residual tissue repositories as a resource for population-based cancer proteomic studies. | Clin Proteomics | 2018 |
| 30194412 | Right data for right patient-a precisionFDA NCI-CPTAC Multi-omics Mislabeling Challenge. | Nat Med | 2018 |
| 29443976 | How many human proteoforms are there? | Nat Chem Biol | 2018 |
| 27836980 | Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction. | Mol Cell Proteomics | 2017 |
| 29124938 | Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues. | J Proteome Res | 2017 |
| 27836980 | Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction. | Mol Cell Proteomics | 2017 |
| 29124938 | Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft Tissues. | J Proteome Res | 2017 |
| 26867747 | Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays. | Methods Mol Biol | 2016 |
| 27372738 | Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. | Cell | 2016 |
| 26867747 | Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays. | Methods Mol Biol | 2016 |
| 26719571 | Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. | Clin Chem | 2016 |
| 26653538 | Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts. | J Proteome Res | 2016 |
| 26503891 | Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts. | Mol Cell Proteomics | 2016 |
| 26653538 | Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts. | J Proteome Res | 2016 |
| 26503891 | Integrated Bottom-Up and Top-Down Proteomics of Patient-Derived Breast Tumor Xenografts. | Mol Cell Proteomics | 2016 |